Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Translational Sciences Lead (m/f/d) YOUR TASKS AND RESPONSIBILITIES The Translational Sciences Lead (TSL) is pivotal in advancing our oncology portfolio, creating significant impact through the progression of global development programs and pipeline expansion from early target
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
YOUR TASKS AND RESPONSIBILITIES The Translational Sciences Lead (TSL) is pivotal in advancing our oncology portfolio, creating significant impact through the progression of global development programs and pipeline expansion from early target assessment through life cycle